Women with germline BRCA1 or BRCA2 mutations are recommended to undergo salpingo-oophorectomy bilateral (prophylactic oophorectomy, RRSO) to reduce their risk of developing ovarian cancer (and breast cancer), usually by age 40 or after the completion of child bearing [66]. The gene discussed is BRCA1; the disease is breast carcinoma.